208 |
Insulin receptor (INSR), |
5500 |
SUMO-1 activating enzyme subunit 1 (SAE1), |
6292 |
Tumor susceptibility gene 101 (TSG101), |
12248 |
Selenophosphate synthetase 2 (SPS2), |
6217 |
Serine (or cysteine) proteinase inhibitor, clade I |
|
(neuroserpin), member 2 (SERPINI2), |
16614 |
TRAF and TNF receptor-associated protein (TTRAP), |
6437 |
ADP-ribosyltransferase-like 1 (ADPRTL1) |
33306 |
Caspase 4, apoptosis-related cysteine protease |
|
(CASP4), transcript variant gamma, |
L04731 |
Translocation T (4:11) of ALL-1 gene |
2085 |
Glutathione peroxidase 4 (phospholipid |
|
hydroperoxidase) (GPX4), |
4728 |
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide |
|
21 (DDX21), |
2624 |
Prefoldin 5 (PFDN5), transcript variant 1, |
6415 |
Serine palmitoyl transferase, long chain base |
|
subunit 1 (SPTLC1), |
4127 |
G protein pathway suppressor 1 (GPS1), |
14887 |
Hypothetical protein from BCRA2 region |
660 |
Transforming growth factor, beta 1 (TGF-β 1), |